Skip to content
10-Q

Quarterly Report

INTEC PHARMA LTD.

0001493152-21-011671

← back to feed
Filed
May 17, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 13, 2021 4.82M sh
Capex Q1 2021 · Mar 31, 2021 $1K
Capex Q1 2021 · Mar 31, 2020 $3K
Operating Cash Flow Q1 2021 · Mar 31, 2021 −$4.31M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$5.15M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $10.14M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $14.67M
Cash And Equivalents Q1 2021 · Mar 31, 2020 $10.89M
Stockholders Equity Q1 2021 · Mar 31, 2021 $11.34M
Stockholders Equity Q1 2021 · Dec 31, 2020 $14.53M
Stockholders Equity Q1 2021 · Mar 31, 2020 $14.22M
Stockholders Equity Q1 2021 · Dec 31, 2019 $11.54M
Current Liabilities Q1 2021 · Mar 31, 2021 $5.2M
Current Liabilities Q1 2021 · Dec 31, 2020 $5.33M
Total Liabilities Q1 2021 · Mar 31, 2021 $6.09M
Total Liabilities Q1 2021 · Dec 31, 2020 $6.36M
Current Assets Q1 2021 · Mar 31, 2021 $12.16M
Current Assets Q1 2021 · Dec 31, 2020 $14.97M
Total Assets Q1 2021 · Mar 31, 2021 $17.43M
Total Assets Q1 2021 · Dec 31, 2020 $20.9M
Sga Expense Q1 2021 · Mar 31, 2021 $2.02M
Sga Expense Q1 2021 · Mar 31, 2020 $1.72M
Rd Expense Q1 2021 · Mar 31, 2021 $2.16M
Rd Expense Q1 2021 · Mar 31, 2020 $2.02M
Net Income Q1 2021 · Mar 31, 2021 −$4.23M
Net Income Q1 2021 · Mar 31, 2020 −$3.87M
Operating Income Q1 2021 · Mar 31, 2021 −$4.18M
Operating Income Q1 2021 · Mar 31, 2020 −$3.74M